Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

Research output: Contribution to conferencePaper

Standard Standard

Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? / Hughes, D.; Hughes, D.A.; Pirmohamed, M.

2003. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, .

Research output: Contribution to conferencePaper

HarvardHarvard

Hughes, D, Hughes, DA & Pirmohamed, M 2003, 'Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?' Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, 3/01/01, .

APA

Hughes, D., Hughes, D. A., & Pirmohamed, M. (2003). Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, .

CBE

Hughes D, Hughes DA, Pirmohamed M. 2003. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, .

MLA

VancouverVancouver

Hughes D, Hughes DA, Pirmohamed M. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. 2003. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, .

Author

Hughes, D. ; Hughes, D.A. ; Pirmohamed, M. / Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, .

RIS

TY - CONF

T1 - Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

AU - Hughes, D.

AU - Hughes, D.A.

AU - Pirmohamed, M.

PY - 2003/11/1

Y1 - 2003/11/1

M3 - Paper

ER -